Science News & Science Current Events
 
Email a Friend Send to a friend
Printer Friendly Print New discoveries from Harvard and Baylor get to the heart of cardiovascular disease

New discoveries from Harvard and Baylor get to the heart of cardiovascular disease

June 19, 2008

Even if you eat right and exercise regularly, chances are high that you'll still die of a heart attack or stroke. But thanks to new findings by researchers from Harvard and Baylor, the odds may finally shift in your favor. Two unrelated studies recently published online in The FASEB Journal (http://www.fasebj.org) describe findings on atherosclerosis that have the potential to save millions of lives.

Both studies involved experiments in mice, but cover biological processes present in humans. In the first, scientists from Harvard explain how the absence of a single protein, called "ROCK1," profoundly reduces inflammation in the walls of blood vessels provoked by fatty deposits (atherosclerosis). In this study, scientists found that ROCK1 is necessary for immune cells, called macrophages, to "clean up" vascular walls when they come into contact with fatty deposits. Inflammation is a normal byproduct of the clean-up process and, when it goes unchecked, leads to clogging and hardening of the arteries. When ROCK1 is absent, macrophages no longer contributed to these fatty deposits and mice showed significantly less inflammation and atherosclerosis. This discovery could lead to new treatments, such as ROCK1 inhibitors, that could dampen the inflammatory response to fatty deposits and slow the progression of atherosclerosis, and in so doing, reduce the incidence of heart attacks and strokes.




According to James Liao, MD, Director of Vascular Medicine Research, Brigham and Women's Hospital, Harvard Medical School, and one of the report's co-authors, "the ultimate goal of the research is to prevent or slow atherosclerosis, and these findings provide a new target to do this."

While the first study works to prevent inflammation by keeping cells of the immune system at bay, the second report focuses on the body's ability (or inability) to "cool down" inflammation after this clean-up machinery kicks into high gear. Separate researchers from Harvard, Brigham and Women's Hospital and Baylor looked at how we prevent inflammation from running amok. The scientists identified lipid mediators that the body uses to resolve inflammation once it has started. By targeting these lipid mediators and the mechanisms used to make them, scientists should be able to develop drugs that significantly reduce the inflammation that underlies much of atherosclerosis.

"The specific chemical mediators that naturally cool down the inflammatory process identified in this study represent a new drug target for anti-atherosclerosis therapy," said Aksam Merched, PhD, Assistant Professor at Baylor College of Medicine and the first author of the study. "It's also noteworthy that aspirin stimulates the body to produce one class of these chemicals."

"Even if we delay the process by exercise and rabbit food, sooner or later our blood vessels rot," said Gerald Weissmann, MD, Editor-in-Chief of The FASEB Journal. "Now that we appreciate that atherosclerosis is inflammation gone awry, we can attack its root causes. Studies like these take us closer to delaying the inevitable, and help us understand the factors that provoke heart attacks and strokes."

And as the first study aims to prevent atherosclerosis before the immune system kicks into gear and the second aims to prevent it after the immune system is activated, a third study appearing on the cover of the June 2008 print issue of The FASEB Journal (www.fasebj.org) discusses a new approach toward repairing the damage using artificial grafts that may heal into the natural arteries and blood vessels as time goes on. Find out more about this by visiting The FASEB Journal online at www.fasebj.org and clicking "Press Room."

According to the U.S. Centers for Disease Control and Prevention, heart disease is the number one killer of Americans and a major cause of disability. About 29 percent of all U.S. deaths are from heart disease (approximately 700,000 a year). Stroke is the leading cause of disability in the United States and the third leading cause of death. By reducing the incidence of atherosclerosis, the risk of fatal heart attacks or strokes would decrease significantly.

Federation of American Societies for Experimental Biology



Related Atherosclerosis Current Events and Atherosclerosis News Articles Atherosclerosis Current Events and Atherosclerosis News RSS Atherosclerosis Current Events and Atherosclerosis News RSS
LIAI launches new division to look at novel approaches to heart disease and inflammation
While cholesterol-lowering drugs and new technologies have significantly advanced the nation's battle against heart disease, it continues to rank as the No. 1 killer of U.S. men and women. But if researchers at the La Jolla Institute for Allergy & Immunology (LIAI) have their way, the body's immune system will become an important player in reducing heart disease.

Surgery unnecessary for 95 percent of those with asymptomatic carotid stenosis
Research led by Dr. David Spence of Robarts Research Institute at The University of Western Ontario shows that with more intensive medical therapy, the risk of stroke has become so low that at least 95 per cent of patients with asymptomatic carotid stenosis (ACS) would be better off with medical therapy than with surgery or stenting.

Penn Researchers Show that Inhibiting Cholesterol-Associated Protein Reduces High-Risk Blockages in Arteries
Using the drug darapladib, researchers at the University of Pennsylvania School of Medicine and colleagues have inhibited a cholesterol-and immune system-associated protein, thereby reducing the development of heart-disease plaques that may cause death, heart attacks, and strokes in a pig model of atherosclerosis and diabetes.

Aspirin and atherosclerosis
Aspirin has become one of the most widely used medications in the world, owing to its ability to reduce pain, fevers, inflammation, and blood clotting.

3-D MRI technique helps radiologists detect high-risk carotid disease
Canadian researchers have used three-dimensional magnetic resonance imaging (3-D MRI) to accurately detect bleeding within the walls of diseased carotid arteries, a condition that may lead to a stroke.

Key protein molecule linked to diverse human chronic inflammatory diseases
Liwu Li, associate professor of biological sciences at Virginia Tech, has revealed a common connection between the cellular innate immunity network and human chronic inflammatory diseases, including atherosclerosis, Type 2 Diabetes, and neurodegenerative diseases.

Brush your teeth to reduce the risk of heart disease
Heart disease is the leading cause of death worldwide. However, many people with cardiovascular disease have none of the common risk factors such as smoking, obesity and high cholesterol.

'Healthy' individuals may be at risk for heart disease
In the face of a growing obesity epidemic in the United States, researchers at Wake Forest University Baptist Medical Center have new study results that indicate that how much fat a person has is not as important as where that fat is located when assessing risk for cardiovascular events and metabolic disease.

Arteries from distinct regions of the body have unique immune functions
Human arteries play distinct roles in the immune system depending on their anatomical location, researchers at Emory University School of Medicine have discovered.

Study shows heavy snoring is an independent risk factor for carotid atherosclerosis
A study in the Sept. 1 issue of the journal Sleep shows that objectively measured heavy snoring is an independent risk factor for early carotid atherosclerosis, which may progress to be associated with stroke.
More Atherosclerosis Current Events and Atherosclerosis News Articles


Unclog Your Arteries : How I Beat Atherosclerosis
by Gene McDougall

Heart attack or bypass surgery? - or even if not- if you are overweight, have high blood pressure, high blood sugar, diabetes, high cholesterol, heart disease, or a family history of any, read this and then keep it for...



Atherosclerosis and Heart Disease

Exploring the entire range of recent advances, Atherosclerosis and Heart Disease covers all aspects of atherosclerotic disease, including chronic manifestations, bypass surgery, stroke prevention and methods to lower blood pressure. Prof. Tonkin brings together a team of internationally-recognized experts to discuss sound clinical practices, based on scientific research and publications. They...

Atherosclerosis and Coronary Artery Disease

This definitive two-volume work provides the most up-to-date and comprehensive coverage available of current approaches to diagnosing and managing atherosclerosis and its coronary and noncoronary complications. Additionally, the book includes fundamental basic science issues, and emphasizes the pathogenetic and pathophysiologic processes affecting atherosclerosis, its risk factors, and...



Atherosclerosis, Large Arteries and Cardiovascular Risk (Advances in Cardiology)

This book presents the current thinking of international experts regarding the underlying mechanisms of cardiovascular risk as well as the pathogenesis and pathophysiology of impaired large arterial stiffness and reduced large arterial distensibility. It also demonstrates the rationale for the present approach to the management and treatment of hypertensive diseases and atherosclerosis. The...



Atlas of Atherosclerosis Progression and Regression, Second Edition (The Encyclopedia of Visual Medicine Series)
by Herbert C. Stary

Completely revised and updated, the Second Edition of the Atlas of Atherosclerosis Progression and Regression contains new material and new illustrations from Dr. Stary's groundbreaking work in the field of atherosclerosis diagnosis, prevention, and treatment. Over 100 photographs show arterial and lesion structure and individual components in unprecedented detail. These images allow you to...



Atlas of Atherosclerosis : Risk Factors and Treatment
by Scott M. Grundy (Editor)

This new edition is an intergral source of information covering topics such as newer coronary risk factors, high- density lipoprotein metabolism, lipid-lowering drugs, endothelium and thrombosis in atherogenesis, and contributing risk factors. With over 500 exceptional photographs, diagrams, and charts, each chapter illustrates an improtant facet of diagnosing and treating this common and often...



Biochemistry of Atherosclerosis (Advances in Biochemistry in Health and Disease)

At its present rate of growth, atherosclerosis will be the major cause of death from disease by the year 2020. Atherosclerosis is an extremely complex, biochemical, multifactorial process. This book will cover many aspects of atherogenesis, with particular emphasis on lipid and lipoprotein metabolism. We will cover all aspects of the regulation of cholesterol homeostasis and the importance of...



The Nutritional Bypass : Reverse Atherosclerosis Without Surgery
by David W. Rowland

Did you know that there is a time tested, safe, non-surgical method of removing arterial blockages-without side effects? Severe arterial blockages do not have to lead to coronary bypass surgery or heart attacks. Inside this book is a complete program for successfully reversing and preventing hardening of the arteries. You may be surprised to know that cholesterol is not the cause of heart...



Etiology and Prevention of Atherosclerosis
by M.D. A. V. Constantini, M.D. Heinrich Wieland, M.D. Lars I. Qvick



New Research on Atherosclerosis

© 2008 BrightSurf.com